OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Topical Cream In Focus

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) has obtained expressions of interest from the medical and scientific communities globally as a result of its recently reported positive initial clinical efficacy tests data of its topical cream targeting Psoriasis.

The details

OWC Pharmaceutical’s scientific team, directed by the famous Dr. Yehuda Baruch, the firm’s Chief Science Officer previously released trial data and stated that post-application of company’s unique, active CBD-based topical cream, they recorded up to 70% improvement in many inflammation markers directly linked with Psoriasis.

This promising data have led them to expand the scope and size of its clinical study and has resulted in directly to receipt of continuing queries and expressions of interest from investigators world-wide for more data on its topical cream for psoriasis treatment and their product’s expected availability for application in the market.

OWC Pharmaceutical actively protects its IP. It will report the final data, clinical data and relevant protocols after the closure of the full bio-data IP protection. Ziv Turner, the Managing Director of OWC Pharmaceutical, commented that as soon as they closed the efficacy results of their pre-clinical psoriasis cure, the company has continued to get active inquiries from many global scientific institutions in nations like Germany, Hungary, the Czech Republic, and more, that adopted or plan to adopt MMJ bills.

The company is in talks for marketing and scientific cooperation deals. In addition, they realistically anticipate product readiness for their topical cream in initial Q3 2017 and, based on regulatory approvals, states and federal laws they can offer their product to psoriasis patients.

Psoriasis comes in the list of autoimmune diseases, and a patient with psoriasis gets red, scaly patches on the skin. The disease can be related with other grave health conditions, including heart disease, depression and diabetes. Skin cells in psoriasis patients grow at an unusually fast rate, triggering a buildup of lesions that burn and itch.

Leave a Reply

Your email address will not be published. Required fields are marked *

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) And STENOCARE Sign An MOU OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Announces Positive Safety Results From The First Phase Study For Medical Cannabis Ointment For Skin Disease Treatment OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Issues Chairman’s Statement to Shareholders CFN Media Interviews OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) CSO OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) To Commence Safety Testing On Its CBD-Infused Cream

Pin It on Pinterest